Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine vs Flu/Cy for Lymphodepletion in CAR-T Therapy
NCT07593482Phase 2Recruiting
- Sponsor
- Swiss Group for Clinical Cancer Research
- Start
- Sep 2026
- Primary completion
- Mar 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in diffuse large B-cell lymphoma (DLBCL), sponsored by Swiss Group for Clinical Cancer Research. Started Sep 2026; status: recruiting.
02
Drugs
bendamustine
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT07593482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07593482.